Free Trial

Design Therapeutics (DSGN) Institutional Ownership

Design Therapeutics logo
$3.77 +0.09 (+2.45%)
As of 07/3/2025 01:01 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Design Therapeutics (NASDAQ:DSGN)

Current
Institutional Ownership
Percentage
56.64%
Number of
Institutional Buyers
(last 12 months)
42
Total
Institutional Inflows
(last 12 months)
$38.43M
Number of
Institutional Sellers
(last 12 months)
20
Total
Institutional Outflows
(last 12 months)
$8.59M
Get DSGN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Design Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

DSGN Institutional Buying and Selling by Quarter

Design Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
6/27/2025Goldman Sachs Group Inc.266,016$1.03M0.0%-10.5%0.469%
5/29/2025Rhumbline Advisers46,369$179K0.0%-12.4%0.082%
5/28/2025Strs Ohio22,600$87K0.0%N/A0.040%
5/21/2025Acadian Asset Management LLC630,953$2.43M0.0%+11.2%1.111%
5/19/2025Jane Street Group LLC18,125$70K0.0%N/A0.032%
5/16/2025Woodline Partners LP645,694$2.49M0.0%N/A1.137%
5/16/2025Goldman Sachs Group Inc.266,016$1.03M0.0%-10.5%0.469%
5/16/2025Almitas Capital LLC1,452,896$5.61M1.9%+9.8%2.559%
5/15/2025MPM Bioimpact LLC562,943$2.17M0.4%+0.6%0.992%
5/15/2025Velan Capital Investment Management LP14,000$54K0.1%N/A0.025%
5/15/2025Driehaus Capital Management LLC913,399$3.53M0.0%+17.7%1.609%
5/14/2025Wellington Management Group LLP141,519$546K0.0%N/A0.249%
5/13/2025American Century Companies Inc.44,415$171K0.0%+13.5%0.078%
5/12/2025Nuveen LLC147,228$568K0.0%N/A0.259%
5/9/2025Charles Schwab Investment Management Inc.258,375$997K0.0%-2.4%0.455%
4/22/2025Palumbo Wealth Management LLC58,278$225K0.1%+6.5%0.103%
4/15/2025Assenagon Asset Management S.A.36,917$142K0.0%-34.8%0.065%
4/8/2025Rhumbline Advisers46,369$179K0.0%-12.4%0.082%
2/18/2025Frazier Life Sciences Management L.P.1,953,547$12.05M0.5%+3.2%3.450%
2/17/2025Squarepoint Ops LLC48,186$297K0.0%-43.4%0.085%
2/17/2025Two Sigma Advisers LP233,900$1.44M0.0%-23.3%0.413%
2/17/2025Two Sigma Investments LP203,931$1.26M0.0%-33.0%0.360%
2/17/2025Point72 Asset Management L.P.1,856,750$11.46M0.0%+16.0%3.279%
2/17/2025ProShare Advisors LLC11,525$71K0.0%N/A0.020%
2/17/2025MPM Bioimpact LLC559,547$3.45M0.5%N/A0.988%
2/17/2025Nuveen Asset Management LLC158,004$975K0.0%-25.7%0.279%
2/17/2025Jacobs Levy Equity Management Inc.18,261$113K0.0%-93.5%0.032%
2/17/2025D. E. Shaw & Co. Inc.512,330$3.16M0.0%-12.1%0.905%
2/17/2025Driehaus Capital Management LLC776,082$4.79M0.0%N/A1.371%
2/17/2025Bridgeway Capital Management LLC128,400$792K0.0%-45.5%0.227%
2/17/2025BNP Paribas Financial Markets40,289$249K0.0%N/A0.071%
2/14/2025Northern Trust Corp388,125$2.40M0.0%+15.2%0.685%
2/14/2025Dimensional Fund Advisors LP215,265$1.33M0.0%+60.2%0.380%
2/13/2025Walleye Capital LLC141,127$871K0.0%+101.6%0.249%
2/13/2025XTX Topco Ltd48,424$299K0.0%N/A0.086%
2/13/2025Barclays PLC103,571$639K0.0%+7.2%0.183%
2/13/2025Kennedy Capital Management LLC14,266$88K0.0%N/A0.025%
2/13/2025Renaissance Technologies LLC253,500$1.56M0.0%-7.5%0.448%
2/13/2025Invesco Ltd.11,583$71K0.0%N/A0.020%
2/13/2025Wells Fargo & Company MN18,428$114K0.0%+27.8%0.033%
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
2/12/2025Geode Capital Management LLC761,640$4.70M0.0%+0.4%1.345%
2/12/2025JPMorgan Chase & Co.89,215$550K0.0%+119.3%0.158%
2/11/2025Prudential Financial Inc.56,315$347K0.0%-4.7%0.099%
2/11/2025American Century Companies Inc.39,115$241K0.0%+19.9%0.069%
2/11/2025Intech Investment Management LLC17,665$109K0.0%N/A0.031%
2/6/2025Charles Schwab Investment Management Inc.264,675$1.63M0.0%+2.8%0.467%
2/4/2025Bank of New York Mellon Corp95,348$588K0.0%-3.8%0.168%
1/30/2025Palumbo Wealth Management LLC54,696$337K0.1%+48.7%0.097%
1/30/2025Rhumbline Advisers52,932$327K0.0%+4.7%0.093%
1/24/2025China Universal Asset Management Co. Ltd.12,006$74K0.0%N/A0.021%
1/14/2025Assenagon Asset Management S.A.56,617$349K0.0%-83.6%0.100%
12/26/2024JPMorgan Chase & Co.40,687$219K0.0%+186.9%0.072%
11/20/2024Virtu Financial LLC46,356$249K0.0%+318.8%0.082%
11/19/2024Barclays PLC96,635$520K0.0%+34.2%0.171%
11/16/2024Geode Capital Management LLC758,550$4.08M0.0%+7.1%1.340%
11/15/2024Frazier Life Sciences Management L.P.1,892,547$10.18M0.4%+58.3%3.342%
11/15/2024Barclays PLC96,635$520K0.0%+34.2%0.171%
11/15/2024Public Employees Retirement System of Ohio8,272$45K0.0%-63.1%0.015%
11/15/2024Jane Street Group LLC24,003$129K0.0%-58.5%0.042%
11/15/2024State Street Corp690,826$3.72M0.0%-0.7%1.220%
11/15/2024Point72 Asset Management L.P.1,600,740$8.61M0.0%+61.6%2.827%
11/15/2024Jacobs Levy Equity Management Inc.280,271$1.51M0.0%-41.2%0.495%
11/15/2024Baker BROS. Advisors LP1,743,725$9.38M0.1%+2.9%3.080%
11/15/2024Paloma Partners Management Co11,902$64K0.0%N/A0.021%
11/14/2024PDT Partners LLC36,099$194K0.0%+33.1%0.064%
11/14/2024Walleye Capital LLC70,000$377K0.0%+16.3%0.124%
11/14/2024MetLife Investment Management LLC19,334$104K0.0%N/A0.034%
11/13/2024Caz Investments LP15,000$81K0.0%-62.5%0.026%
11/13/2024FMR LLC828,665$4.46M0.0%+922.8%1.464%
11/13/2024The Manufacturers Life Insurance Company13,221$71K0.0%N/A0.023%
11/12/2024Charles Schwab Investment Management Inc.257,432$1.39M0.0%+43.0%0.455%
11/5/2024GSA Capital Partners LLP173,744$935K0.1%-17.2%0.307%
10/28/2024Palumbo Wealth Management LLC36,774$198K0.1%+11.3%0.065%
10/3/2024SG Americas Securities LLC12,289$66K0.0%N/A0.022%
9/16/2024Cubist Systematic Strategies LLC23,497$79K0.0%+75.6%0.042%
8/19/2024Point72 Asset Management L.P.990,801$3.32M0.0%+66.9%1.754%
8/16/2024Almitas Capital LLC1,253,248$4.20M1.7%+22.1%2.218%
8/16/2024Frazier Life Sciences Management L.P.1,195,179$4.00M0.2%N/A2.116%
8/14/2024Squarepoint Ops LLC89,955$301K0.0%+146.9%0.159%
8/14/2024Cubist Systematic Strategies LLC23,497$79K0.0%+75.6%0.042%
8/14/2024Marshall Wace LLP24,280$81K0.0%N/A0.043%
8/12/2024Hsbc Holdings PLC44,470$146K0.0%-8.9%0.079%
8/9/2024Renaissance Technologies LLC384,075$1.29M0.0%-15.3%0.680%
8/9/2024Dimensional Fund Advisors LP80,953$271K0.0%+119.7%0.143%
8/8/2024American Century Companies Inc.21,333$71K0.0%N/A0.038%
8/6/2024Acadian Asset Management LLC583,160$1.95M0.0%+44.5%1.032%
7/26/2024Bank of New York Mellon Corp118,110$396K0.0%+2.5%0.209%
5/29/2024Opaleye Management Inc.113,038$456K0.1%N/A0.200%
5/16/2024Jacobs Levy Equity Management Inc.502,020$2.02M0.0%-8.6%0.889%
5/15/2024Baker BROS. Advisors LP1,662,120$6.70M0.1%+10.8%2.942%
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
5/15/2024Public Employees Retirement System of Ohio23,748$96K0.0%-9.8%0.042%
5/15/2024Price T Rowe Associates Inc. MD11,147$45K0.0%N/A0.020%
5/10/2024Acadian Asset Management LLC403,546$1.63M0.0%+123.3%0.714%
5/10/2024Vanguard Group Inc.1,285,962$5.18M0.0%+29.0%2.276%
5/9/2024State Board of Administration of Florida Retirement System12,630$51K0.0%N/A0.022%
5/8/2024Bleakley Financial Group LLC11,495$46K0.0%N/A0.020%
5/7/2024SG Americas Securities LLC11,316$46K0.0%-40.0%0.020%
5/3/2024GSA Capital Partners LLP216,347$872K0.1%+199.3%0.383%
5/1/2024Mirae Asset Global Investments Co. Ltd.14,133$57K0.0%N/A0.025%
4/29/2024Principal Financial Group Inc.12,497$50K0.0%-17.9%0.022%
(Data available from 1/1/2016 forward)

DSGN Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of DSGN shares?

During the previous two years, 80 institutional investors and hedge funds held shares of Design Therapeutics. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($12.05M), Point72 Asset Management L.P. ($11.46M), Baker BROS. Advisors LP ($9.38M), RTW Investments LP ($5.93M), Almitas Capital LLC ($5.61M), Vanguard Group Inc. ($5.18M), and Geode Capital Management LLC ($4.70M).Learn more on Design Therapeutics' institutional investors.

What percentage of Design Therapeutics' stock is owned by institutional investors?

56.64% of Design Therapeutics' stock is owned by institutional investors. Learn more on DSGN's institutional investor holdings.

Which institutional investors have been buying Design Therapeutics' stock?

Of the 67 institutional investors that purchased Design Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($1.95M), Point72 Asset Management L.P. ($1.26M), BML Capital Management LLC ($1.03M), RTW Investments LP ($949.96K), Driehaus Capital Management LLC ($913.40K), FMR LLC ($747.65K), and Woodline Partners LP ($645.69K).

How much institutional buying is happening at Design Therapeutics?

Institutional investors have bought a total of 8,026,935 shares in the last 24 months. This purchase volume represents approximately $38.43M in transactions.

Which of Design Therapeutics' major shareholders have been selling company stock?

Of the 20 institutional investors that sold Design Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Jacobs Levy Equity Management Inc. ($458.00K), Assenagon Asset Management S.A. ($309.28K), Bridgeway Capital Management LLC ($107.20K), Two Sigma Investments LP ($100.31K), Renaissance Technologies LLC ($89.83K), Two Sigma Advisers LP ($71K), and D. E. Shaw & Co. Inc. ($70.53K).

How much institutional selling is happening at Design Therapeutics?

Institutional investors have sold a total of 1,504,010 shares in the last 24 months. This volume of shares sold represents approximately $8.59M in transactions.



This page (NASDAQ:DSGN) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners